Your session is about to expire
← Back to Search
Airway & Compression Techniques for Cardiac Arrest (FACT Trial)
N/A
Recruiting
Led By Thomas Rea, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this outcome occurs within minutes of the cardiac arrest event. the outcome will be monitored for 1 day from the time of cardiac arrest.
Awards & highlights
No Placebo-Only Group
Summary
"This trial will compare two different ways of providing basic life support (BLS) to patients who experience sudden cardiac arrest outside of a hospital setting. It will look at the effectiveness of using a standard Bag
Who is the study for?
This trial is for adults in Seattle and greater King County who experience a sudden, non-traumatic cardiac arrest outside of the hospital where EMS will attempt resuscitation.
What is being tested?
The FACT Study compares two rescue breathing methods (standard Bag Valve Mask vs i-gel) and three chest compression rates (100, 110, or 120 per minute) during CPR to see which leads to better survival rates after cardiac arrest.
What are the potential side effects?
Since both rescue breathing methods and the range of chest compression rates are within current guidelines and standard care, side effects are expected to be those typically associated with CPR.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ this outcome occurs within minutes of the cardiac arrest event. the outcome will be monitored for 1 day from the time of cardiac arrest.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this outcome occurs within minutes of the cardiac arrest event. the outcome will be monitored for 1 day from the time of cardiac arrest.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Survival to Hospital Discharge
Secondary study objectives
Return to Spontaneous Circulation (ROSC)
Survival with favorable neurological function (CPC 1-2)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Compression RateActive Control1 Intervention
Each of 28 first responder EMS agencies in King County will be randomly assigned with one of the three chest compression rates (100 vs 110 vs 120) at the outset.
Group II: Airway StrategyActive Control1 Intervention
Each of 28 first responder EMS agencies in King County will be randomly assigned to treat with either the BVM or i-gel for airway strategy
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,829 Previous Clinical Trials
1,902,894 Total Patients Enrolled
9 Trials studying Cardiac Arrest
5,482 Patients Enrolled for Cardiac Arrest
Thomas Rea, MDPrincipal InvestigatorUniversity of Washington